# nifedipine

### notes
+ prescription under medical supervision

### therapeutic action
+ uterine relaxant
+ antihypertensive drug (calcium channel blocker)

### indications
+ threatened premature labour
+ hypertension

### presentation
+ 10 mg short-acting (liquid-filled) capsule
+ 10 mg prolonged-release tablet

### dosage
+ threatened premature labour (short-acting capsule)  
    10 mg by oral route, to be repeated every 15 minutes if uterine contractions persist (maximum 4 doses or 40 mg), then 20 mg by oral route every 6 hours
+ hypertension (prolonged-release tablets)  
    20 to 100 mg/day in 2 divided doses or 20 to 90 mg once daily depending on the preparation used

### duration
+ threatened premature labour: 48 hours
+ hypertension: lifetime treatment

### contra-indications, adverse effects, precautions
+ do not administer to patients with severe cardiac disease (recent myocardial infarction, unstable angina).
+ do not administer if systolic blood pressure is below 90 mmhg.
+ may cause:
    - headache, flushing, peripheral oedema (common adverse effects at the start of treatment);
    - dizziness, hypotension, tachycardia, nausea, gingival hyperplasia, rash.
+ stop nifedipine if ischaemic chest pain occurs or existing pain increases shortly after starting treatment.
+ do not combine with magnesium sulphate, salbutamol iv, and calcium channel blockers.
+ monitor combination with cimetidine (additive hypotension), phenytoin (risk of phenytoin toxicity), rifampicin (efficacy of nifedipine diminished), itraconazole (increased risk of oedema), beta-blockers (enhanced antihypertensive effects).
+ *pregnancy*: contra-indicated during the 1st trimester. never administer sublingually (risk of foetal death from placental hypoperfusion).
+ *breast-feeding*: avoid

### remarks
+ for the management of hypertension in pregnancy, use labetalol or methyldopa.
+ short-acting formulations of nifedipine should not be used in hypertension since their use may cause excessive fall in blood pressure and cerebral or myocardial ischaemia.
+ prolonged-release tablets must be swallowed whole.
+ also comes in 20 mg, 30 mg, 60 mg and 90 mg prolonged-release tablets to be administered once daily or to be administered twice daily. follow manufacturer's instructions.
+ storage: below 25Â°c